logo

For the Inventor, By the Inventor

Tortola, Virgin Islands, British

Biohaven Therapeutics Ltd.


USPTO Granted Patents = 32


Trademarks = 17

Forward Citations = 47

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Allen B Reitz (12 out of 101 patents)

silverMedal Jay Edward Wrobel (11 out of 96 patents)

bronzeMedal Garry Robert Smith (11 out of 33 patents)

4.  Haiyan Bian (10 out of 35 patents)

5.  Jeffery Claude Pelletier (8 out of 11 patents)

6.  Vladimir Coric (8 out of 16 patents)

7.  Robert Berman (7 out of 7 patents)

8.  Lynn Resnick (4 out of 14 patents)

9.  George T Topalov (4 out of 31 patents)

10.  Justin K Belardi (4 out of 12 patents)

11.  Charles A Flentge (4 out of 14 patents)

12.  David A Mareska (4 out of 25 patents)

13.  James S Hale (4 out of 14 patents)

14.  Scott S Harried (4 out of 30 patents)

15.  Michael E Bozik (3 out of 26 patents)


Core Competencies:
Riluzole Prodrugs
KV7 Channel Activators
Immunotherapy
Graves Disease
Alzheimer's Disease
Cancer Treatment
Topical Formulations
Combination Therapy
Galactose-Deficient Immunoglobulins
Furoimidazopyridine
Sublingual Formulation
CD16A Binding Agents

32 patents:

1. 12685782 - BIFUNCTIONAL DEGRADERS FOR THE TREATMENT OF GRAVES DISEASE (2026-07-21),
2. 12673111 - BIFUNCTIONAL DEGRADERS OF GALACTOSE-DEFICIENT IMMUNOGLOBULINS (2026-07-07),
3. 12564579 - Topical formulations of (1S)-1-phenyl-2-pyridin-2-ylethanamine (2026-03-03),
4. 12491246 - Combination therapy of arms and natural killer cells (2025-12-09),
5. 12472165 - Riluzole prodrugs and their use (2025-11-18),
6. 12383619 - Use of glutamate modulating agents with immunotherapies to treat cancer (2025-08-12),
7. 12370176 - Methods of use for KV7 channel activators (2025-07-29),
8. 12364687 - Use of riluzole oral disintegrating tablets for treating diseases (2025-07-22),
9. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators (2025-07-08),
10. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis (2025-07-01),
11. 12297206 - Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of salt (2025-05-13),
12. 12295942 - Riluzole prodrugs and their use (2025-05-13),
13. 12286408 - KV7 channel activators compositions and methods of use (2025-04-29),
14. 12213965 - Riluzole prodrugs and their use (2025-02-04),
15. 12201618 - Use of riluzole prodrugs to treat Alzheimer's disease (2025-01-21),
Company Overview
Biohaven Therapeutics Ltd. is a biopharmaceutical company focused on developing innovative therapies for neurological and psychiatric disorders. The organization specializes in the research and commercialization of novel treatments aimed at addressing unmet medical needs in these areas. With a commitment to advancing science and improving patient outcomes, Biohaven leverages its expertise in drug development and clinical research to bring new solutions to market. The company operates with a global perspective, aiming to make a significant impact in the healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#20 in Tortola

#23 in Virgin Islands, British

#20,671 in the World

Tortola, VG
Tortola, Virgin Islands, British

Biohaven Therapeutics Ltd.

Forward Citations = 47

53 inventors:

goldMedal Allen B Reitz (12 out of 101 patents)

silverMedal Jay Edward Wrobel (11 out of 96 patents)

bronzeMedal Garry Robert Smith (11 out of 33 patents)

4.  Haiyan Bian (10 out of 35 patents)

5.  Jeffery Claude Pelletier (8 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biohaven Therapeutics Ltd.. Retrieved from https://idiyas.com/company/biohaven-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…